+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Inflammation Drug"

Crohn's Disease (CD) Treatment Market Report 2025 - Product Thumbnail Image

Crohn's Disease (CD) Treatment Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Axial Spondyloarthritis (AxSpA) Market Report 2025 - Product Thumbnail Image

Axial Spondyloarthritis (AxSpA) Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Gout Therapeutics Market Report 2025 - Product Thumbnail Image

Gout Therapeutics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Non-Steroidal Anti-inflammatory Drugs Market Report 2025 - Product Thumbnail Image

Non-Steroidal Anti-inflammatory Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Autoimmune Treatment Market Report 2025 - Product Thumbnail Image

Autoimmune Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Celiac Disease Treatment Global Market Report 2025 - Product Thumbnail Image

Celiac Disease Treatment Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
Tenosynovitis Drugs Global Market Report 2025 - Product Thumbnail Image

Tenosynovitis Drugs Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
Upadacitinib Global Market Report 2025 - Product Thumbnail Image

Upadacitinib Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
From
From
From
From
Lodine Tincture Market - Global Forecast 2025-2030 - Product Thumbnail Image

Lodine Tincture Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 183 Pages
  • Global
From
Systemic Lupus Erythematosus Market - Global Forecast 2025-2030 - Product Thumbnail Image

Systemic Lupus Erythematosus Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 195 Pages
  • Global
From
Psoriatic Arthritis - Pipeline Insight, 2025 - Product Thumbnail Image

Psoriatic Arthritis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Crohns Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Crohns Disease - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 100 Pages
  • Global
From
Still's Disease- Pipeline Insight, 2025 - Product Thumbnail Image

Still's Disease- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Plaque Psoriasis - Pipeline Insight, 2025 - Product Thumbnail Image

Plaque Psoriasis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 240 Pages
  • Global
From
Loading Indicator

The Immune Disorders Drugs market is composed of drugs used to treat a variety of conditions related to the immune system. These drugs are used to treat autoimmune diseases, allergies, and other conditions that affect the body's ability to fight off infection. Inflammation drugs are a subset of these drugs, used to reduce inflammation and swelling caused by an immune response. These drugs can be used to treat a variety of conditions, including rheumatoid arthritis, psoriasis, and Crohn's disease. They can also be used to reduce the risk of infection in patients with weakened immune systems. Inflammation drugs are typically administered orally or intravenously, and can be taken as a single dose or as part of a longer-term treatment plan. Common side effects of these drugs include nausea, vomiting, and diarrhea. Companies in the Immune Disorders Drugs market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more